Major step towards individual cancer immunotherapy
ETH spin-off founded for commercial further development of technique
02-Apr-2019 -
Medicine has great hopes for personalised cancer immunotherapy. The idea is to have a vaccine prompt the immune system to fight a tumour. Scientists at ETH Zurich have developed a method that allows them to determine which molecules are suited to patient-specific immunisation.
Cells belonging to ...
cancer
cancer immunotherapies
immune cells
+4